Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DALFAMPRIDINE Cause Progressive multiple sclerosis? 89 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Progressive multiple sclerosis have been filed in association with DALFAMPRIDINE (Dalfampridine). This represents 0.2% of all adverse event reports for DALFAMPRIDINE.

89
Reports of Progressive multiple sclerosis with DALFAMPRIDINE
0.2%
of all DALFAMPRIDINE reports
6
Deaths
19
Hospitalizations

How Dangerous Is Progressive multiple sclerosis From DALFAMPRIDINE?

Of the 89 reports, 6 (6.7%) resulted in death, 19 (21.3%) required hospitalization, and 1 (1.1%) were considered life-threatening.

Is Progressive multiple sclerosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DALFAMPRIDINE. However, 89 reports have been filed with the FAERS database.

What Other Side Effects Does DALFAMPRIDINE Cause?

Gait disturbance (8,780) Drug ineffective (6,794) Fall (5,554) Therapy cessation (4,580) Fatigue (3,778) Balance disorder (3,753) Multiple sclerosis relapse (3,322) Condition aggravated (3,240) Dizziness (2,959) Urinary tract infection (2,757)

What Other Drugs Cause Progressive multiple sclerosis?

DIMETHYL (110) INTERFERON BETA-1A (105) NATALIZUMAB (99) GLATIRAMER (77) FINGOLIMOD (73) OCRELIZUMAB (63) TERIFLUNOMIDE (48) OFATUMUMAB (26) OMEPRAZOLE (25) DULOXETINE (24)

Which DALFAMPRIDINE Alternatives Have Lower Progressive multiple sclerosis Risk?

DALFAMPRIDINE vs DALTEPARIN DALFAMPRIDINE vs DAMOCTOCOG ALFA PEGOL DALFAMPRIDINE vs DANAPAROID DALFAMPRIDINE vs DANAZOL DALFAMPRIDINE vs DANICOPAN

Related Pages

DALFAMPRIDINE Full Profile All Progressive multiple sclerosis Reports All Drugs Causing Progressive multiple sclerosis DALFAMPRIDINE Demographics